Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from TruScreen Group Ltd. ( (AU:TRU) ) is now available.
TruScreen Group Limited announced an update regarding their Share Purchase Plan (SPP), which was oversubscribed beyond the company’s 10% capacity. An administrative error initially led to incorrect notifications to shareholders about their share entitlements. The company has corrected this error, ensuring each investor receives their correct pro-rata entitlement within the available capacity. Additional shares applied for will be issued after a special meeting, pending shareholder approval. The company’s share registrar is holding any excess funds in trust.
More about TruScreen Group Ltd.
TruScreen Group Limited operates in the medical technology industry, focusing on the development and distribution of real-time cervical cancer screening devices. The company is listed on both the NZX and ASX, indicating its market focus spans New Zealand and Australia.
Average Trading Volume: 439,935
Technical Sentiment Signal: Sell
Current Market Cap: A$12.47M
See more data about TRU stock on TipRanks’ Stock Analysis page.